Booth, T. C., Wiegers, E. C., Warnert, E. A. H., Schmainda, K. M., Riemer, F., Nechifor, R. E., . . . Henriksen, O. M. (2022). High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics. Frontiers in Oncology, 11, . https://doi.org/10.3389/fonc.2021.811425

Booth, Thomas C., et al. "High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics." Frontiers in Oncology 11 (2022). https://doi.org/10.3389/fonc.2021.811425.

Booth, Thomas C., et al. "High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics." Frontiers in Oncology, vol. 11, 2022, https://doi.org/10.3389/fonc.2021.811425.